-
Ewing's Sarcoma Treatment Market to Grow by USD 181.3 Million (2025-2029), Boosted by Growing Awareness and Funding, AI Impact on Market Trends - Technavio
21 Jan 2025 04:44 GMT
… are developing pipeline drugs. Treatment may include surgery, … Ewings sarcoma, numerous pharmaceutical companies are investigating … loss require immediate medical attention. Treatment options include surgery … , TEMODAR, and Topotecan with radiation therapy …
-
List of Medicines Made From Plants
15 Jan 2025 20:36 GMT
Drug/;Chemical
Action
Plant Source
… , sea poppy)
Glasiovine
Antidepressant
Octea glaziovii
Glycyrrhizin
Sweetener, treatment for Addison's …
Topical antifungal
Thymus vulgaris (thyme)
Topotecan
Antitumor, anticancer agent
Camptotheca acuminata
…
-
Ewing Sarcoma Market Report 2034: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight
06 Jan 2025 19:17 GMT
… Drugs
Seclidemstat: Salarius Pharmaceuticals
ZEPZELCA (lurbinectedin): Jazz Pharmaceuticals … comprehensive clinical trials for … treatments. These treatments typically involve regimens such as topotecan … Sarcoma Current Treatment and Medical Practices
10 …
-
Small cell lung cancer: Navigating the global clinical trial landscape
16 Dec 2024 15:20 GMT
… refractory cases, treatment options include lurbinectedin, topotecan, or clinical trials. These … therapies, such as antibody-drug conjugates like ifinatamab deruxtecan, … Trial Management and Global Operations, Frost & Sullivan 2024 Global Biotech …
-
GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227, receives EMA Priority Medicines (PRIME) Designation in relapsed extensive-stage small-cell lung cancer
16 Dec 2024 07:18 GMT
… types with limited treatments. Our investigational B7 … trials in China. GSK’s global phase I trial … References
European Medicine Agency. PRIME – Priority Medicines factsheet. … Topotecan USP. Available at: https://www.accessdata.fda.gov/drugsatfda …
-
Human medicines European public assessment report (EPAR): Topotecan Hospira, topotecan, Date of authorisation: 09/06/2010, Revision: 20, Status: Authorised
13 Dec 2024 14:14 GMT
Treatment with Topotecan Hospira should only be given … under the supervision of a doctor … haemoglobin should be checked before treatment, to ensure that they … to be adjusted or other medicines given to the patients, when …
-
Abbvie Receives European Commission Approval Of ELAHERE® (Mirvetuximab Soravtansine) For The Treatment Of Platinum-Resistant Ovarian Cancer
18 Nov 2024 07:30 GMT
… -directed antibody drug conjugate (ADC) medicine approved in the … label, randomized, controlled trial.
Trial participants were 18 … doxorubicin, or topotecan) in the treatment of platinum-resistant … doctor. If a patient becomes pregnant during treatment …
-
Elraglusib Gains FDA Rare Pediatric Disease Designation in Ewing Sarcoma
13 Nov 2024 00:05 GMT
… 1/2 Actuate-1902 trial (NCT04239092) is evaluating elraglusib in … with elraglusib in combination with topotecan and cyclophosphamide were included in … ;NCT04239092
Actuate receives FDA orphan drug designation for elraglusib for treatment of soft …
-
Actuate Announces FDA Rare Pediatric Disease Designation Granted to Elraglusib for Treatment of Ewing Sarcoma
12 Nov 2024 13:00 GMT
… topotecan/cyclophosphamide. Rare Pediatric Disease Designation is granted by the FDA … Drug Application (NDA) for elraglusib for the treatment … and early clinical trials are not … competition from other biotechnology and pharmaceutical companies; our …
-
FDA Grants Rare Pediatric Disease Designation to Elraglusib for Ewing Sarcoma
13 Nov 2024 15:56 GMT
… ongoing phase 1/2 trial show promising anti-tumor activity … treated with the study drug combined with topotecan/cyclophosphamide.1
The … , the FDA granted orphan drug designation to elraglusib for the treatment of individuals …
About
© 1995-2025